MAPT and Cognitive impairment: Given that cortical hypermetabolism and atrophy are also locally associated with tau distribution and mediate the effects of tau pathology on cognitive deficits [18–25], a distinct pattern of cortical tau pathology can be expected to be a key factor in the clinical and neuroimaging characteristics of EOAD.